Developing disease-modifying small molecule compounds that prevent the protein misfolding and aggregation seen in Alzheimer’s and other neurodegenerative diseases.
Active Portfolio Company
www.treventis.com
Location: Canada, Ontario, Toronto
Total raised: $4.4M
Investors 1
| Date | Name | Website |
| - | BioAdvance | bioadvance... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 19.09.2013 | - | $4.4M | - |
Mentions in press and media 2
| Date | Title | Description | Source |
| 07.09.2022 | Arpeggio Biosciences rakes in $17M to measure the transcript... | How can drug developers design therapies around cellular networks rather than a single target? That... | medcitynew... |
| 19.09.2013 | Treventis Corporation Receives $4.4M Seeding Drug Discovery ... | Southeastern Pennsylvania-based Treventis Corporation received a $4.4m Seeding Drug Discovery Award ... | finsmes.co... |